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Human papillomavirus (HPV) types 16 and 18 have 
been identified in two different human cervical carci­
nomas. The viral DN As were molecularly cloned and 
used as probes to screen a large number of genital tumors 
by Southern blot analysis. HPV-16 or HPV-18 se­
quences, respectively, were found in a high percentage 
of cervical carcinomas, but only in a small number of 
condylomata acuminata or flat condylomas. The major­
ity of the latter lesions, however, contained HPV -6 or 
HPV-ll sequences, respectively, which in contrast were 
detected only rarely in carcinomas in situ or invasively 
growing carcinomas. A similar distribution of the dif­
ferent papillomaviruses was observed when cell swabs 
taken from the cervix were tested by in situ hybridiza­
tion. 
The involvement of an infectious event in the development 
of human cancer of the uterine cervix has been implicated for 
many years. This was mainly based on epidemiologic studies 
that showed that the time of first intercourse and the number 
of sexual partners are most important factors associated with 
cervical neoplasia [1). Women whose husbands have multiple 
sexual partners are also at relatively higher risk [2J. Besides 
other agents, herpes simplex virus (HSV) has been extensively 
investigated for its association with cervical carcinomas. Sero­
logic data in fact support the hypothesis that this virus might 
play a role in tumor development, but almost all attempts to 
detect viral DNA within the biopsies gave negative results [3J. 
However, human papillomaviruses have been discussed as pos­
sible candidates for a few years [4] for the following reasons: 
1. The oncogenic potential of some papillomaviruses, e.g., of 
the Shope papillomaviruses and the bovine papillomavirus, 
is well documented [5,6]. 
2. An eventual malignant conversion of certain virus-induced 
human papillomas (e.g., laryngeal papillomas, genital warts, 
lesions in epidermodysplasia verruciformis patients) has 
been reported [4,6]. 
3. Venerally transmitted papillomavirus infections of the gen­
ital tract are very frequent. Approximately 2% of unselected 
women were shown to be affected by genital papillomas [7]. 
4. Mainly due to investigations by Meisels and coworkers it 
became clear that cervical lesions that have been diagnosed 
as mild dysplasia are in fact papillomavirus-associated con­
dylomas [8,9]. It is known, however, that these dysplasias 
progress with a certain probability to cervical intraepithelial 
neoplasia grades II and III and to invasive cancer. 
Human papillomaviruses represent a very heterogeneous 
group. At least 24 different virus types have been identified 
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thus far [10J that are found in particular lesions and whose 
genomes show only a limited, if any, sequence homology with 
each other. Considering this property, it is not surprising that 
the first attempts to detect papillomavirus DNA in genital 
tumors have been unsuccessful, since DNA prepared from skin 
wart viruses has been used as probe in these hybridization 
experiments [11,12]. 
The concentration of papillomavirus particles in genital 
warts is extremely low. Since no permissive cell system for 
virus replication has been established thus far [5], molecular 
cloning of the DNA was a prerequisite in order to investigate 
its presence in different tumors. By centrifugation in a cesium 
chlorid-ethidium bromide equilibrium gradient, the supercoiled 
viral DNA was purified directly from the total cellular DNA 
derived from a genital wart without prior purification of virus 
particles [13]. The yield of viral DNA obtained by this method 
was in some tumors 10 to 50 ng, which was sufficient for 
molecular cloning in the E. coli plasmid pBR322 [14]. 
The cloned DNA was tested by hybridization with DNA 
extracted from virus particles that had been purified from the 
same genital wart. Because of the high sensitivity of DNA 
hybridization (only 106 molecules are necessary), the low con­
centration of papillomavirus present in genital warts was suf­
ficient to clearly identify the cloned DNA as the papillomavirus 
genome [10]. 
Comparison with the other HPV types by restriction enzyme 
analysis and by hybridization indicated this DNA to be a new 
papillomavirus, designated as HPV -6 [13]. The DNA of a 
closely related virus, HPV -11, which was first observed in a 
laryngeal papilloma, was cloned from a genomic library in 
bacteriophage A [15). The HPV DNA-positive plaques were 
identified by in situ hybridization using HPV-6 DNA as a 
probe. HPV-6 and HPV-ll DNA were cleaved from the vector 
by the respective restriction endonuclease, purified in agarose 
gels, and radioactively labeled with 32p_ TTP by nick transla­
tion. For Southern blot experiments, cellular DNA extracted 
from different clinical biopsies was cleaved with restriction 
enzymes, run through an agarose gel, denatured by alkaline 
treatment, transferred onto a nitrocellulose filter, and incu­
bated with the labeled HPV DNA with different concentrations 
of formamide (see below), 0.8 M Na+ at 42°C. 
Using stringent conditions of hybridization (50% formamide 
corresponding to 20"C below Tm), it has been shown that the 
majority of genital warts (96 of 106 cases tested) contained 
sequences of HPV-6 in two-thirds and HPV-11 in one-third of 
the cases ([16,17] and Ikenberg, Gissmann, and zur Hausen, 
unpublished data). Both viruses are closely related [15], and no 
type-specific differences in clinical appearance or histologic 
picture could be observed between the individual papillomas 
containing one or the other virus (Gross, Ikenberg, and Giss­
mann, in preparation). Therefore, in the following, the respec­
tive lesions will be classified as HPV -6 or HPV -11 positive. 
Forty-two percent of flat condylomas associated with dysplasias 
of different severity contained HPV-6 or HPV-ll, which have 
been found only once in 29 cases of cet'vical carcinoma biopsies 
tested thus far ([ 17] and Ikenberg, Gissmann, and zur Hausen, 
unpublished data). 
As stated earlier, many of the different human papillomavirus 
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DNAs do not cross-react with each other under hybridization 
conditions of high stringency (200C below the T m). If the 
temperature of hybridization is lowered to 40°C below the Tm 
(20% formamide, 0.8 M Na+, 42°C), one can detect papilloma­
virus sequences of even more distantly related types ( [18) and 
Gissmann, unpublished data). Using these conditions, two thus 
far unknown human papillomaviruses were identified by South­
ern blot hybridization in two different cervical carcinomas 
[19,20). After cloning, these DNAs were analyzed by restriction 
enzyme analysis and found to be different from the other 
papillomaviruses described thus far. 
Although these molecules have never been detected in pap­
illomavirus particles, it seems to be justified to designate them 
as viral DNA [10), since 
l. They have the same size (approximately 8 kb) as papillo­
mavirus DNA. 
2. At least in some tumors they persist as 8-kb circular DNA, 
i.e., as a molecule which theoretically can be packaged into 
virus particles. 
3. They hybridize with other papillomaviruses under non­
stringent conditions. 
4. They are colinear with well-characterized human papillo­
maviruses, as shown by hybridization of single fragments. 
The new isolates from cervical carcinomas have been labeled 
as HPV -16 and HPV -18, respectively. They were used as probes 
to screen additional tumors by Southern blot analyses under 
stringent conditions of hybridization. It turned out that HPV-
16 or HPV-18, respectively, were present in 6.1 % of condylom­
ata acuminata, 16.7% of flat condylomas, but in 53.8% of 
carcinomata in situ and in 57.4% of cervical cancers ( [19,20) 
and Ikenberg, Gissmann, and zur Hausen, unpublished data). 
Using the in situ hybridization technique on frozen sections of 
four different carcinomas, it was shown that the specific label 
is restricted to the tumor cells (Grussendorf-Conen, Ikenberg, 
and Gissmann, submitted). The data clearly show a preferential 
association of HPV -16 and HPV -18 with malignant tumors 
and might indicate an elevated risk for patients infected with 
these two viruses. 
It should be mentioned here that HPV-16 could be detected 
in 7 of 10 cervical dysplasias containing so-called abnormal 
mitotic figures as indications for a premalignant lesion [21). 
When the negative cervical carcinomas were tested under non­
stringent conditions, 69.6% were shown to contain papilloma­
virus sequences, indicating the presence of at least one addi­
tional thus far uncharacterized virus type in these tumors. 
Thus approximately 90% of cervical carcinoma biopsies harbor 
HPV sequences. 
A similar distribution of different papillomaviruses was found 
when epithelial cells of the cervix regularly taken for routine 
Papanicolaou smears were hybridized in situ with HPV -11 and 
with a mixture of HPV-16 and HPV-18 (Gissmann, Wagner, 
Ikenberg, and Bohm, submitted). Approximately 104 to 106 
epithelial cells were spotted onto a nitrocellulose filter. They 
were treated with alkaline to fix the cells and to denature the 
DNA, which was then hybridized with the 32P-labeled HPV 
probes under stringent conditions. 
No positive reaction with HPV-16 and HPV-18 was seen in 
63 different patients with normal Pap smears, but in 6 of 13 
patients cytologically diagnosed as having mild or moderate 
dysplasia and in 15 of 22 carcinomas in situ, HPV-6 or HPV-
11 sequences were found at frequencies of 4 in 36, 6 in 13, and 
4 in 22, respectively. It will be of interest to follow up those 
patients in whom a clear diagnosis from the Pap smear could 
not be set up but who were positive for HPV-11 or HPV-16 
and HPV-18, respectively. One could expect that only in the 
HPV-16 and HPV-18 positive cases would definite dysplastic 
changes be observed within the next few months. 
The rare occurrence of HPV-16 and HPV-18 DNA in con-
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dylomata acuminata or flat condylomas, respectively, excludes 
the possibility that the DNA derived from carcinomas that 
contain these sequences might be contaminated by adjacent 
genital warts. However, it does raise the question as to which 
primary lesions are induced by HPV-16 or HPV-18, especially 
in the male population. It is attractive to speculate that the 
very often inconspicous but quite frequently occuring Bowenoid 
papules at the glans penis or the vulva (G. Gross, personal 
communication) might represent the reservoir for virus spread, 
at least in case of HPV -16, since viral sequences of this type 
could be found in the majority of such Bowenoid papulosis 
lesions [22). 
The state of the viral DNA within the tumor cells has been 
investigated by cesium chloride-ethidium bromide centrifuga­
tion and two-dimensional electrophoresis. There is evidence 
that in cervical carcinomas the HPV-16 or HPV-18 DNA, 
respectively, is covalently linked to the cellular genome [20). 
This contrasts with the situation in genital warts, where the 
HPV-16 molecules persist exclusively in a nonintegrated form. 
It is an interesting question whether the physical state of the 
viral DNA within a given cell is of influence for malignant 
growth. The high frequency of particular papillomaviruses 
within human genital carcinomas does, of course, per se not 
prove their causative role in tumor development. Epidemiologic 
data clearly indicate the involvement of other factors, e.g., 
herpes simplex virus infection, which might act synergistically 
with those viruses in cell transformation [23). The present 
knowledge of specific virus-cell interactions, however, is still 
refractory, and additional studies on the biological features of 
the papillomaviruses in vivo and in vitro are required to im­
prove our understanding of their role in human genital cancer. 
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